In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Kimberly-Clark mulls a potential spin-off of health care business; Halyard spin-off completed

Executive Summary

Consumer products company Kimberly-Clark Corp. is evaluating a possible tax-free spin-off of its Kimberly-Clark Health Care business via a distribution of the entity’s common stock to K-C Corp. shareholders. If the transaction goes through (anticipated completion would be the end of Q3 2014), K-C Health Care would become an independent publicly traded firm.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Infection Control-Sterilization
    • Infusion Therapy Equipment and Supplies
    • Radiofrequency Devices
    • Surgical Equipment & Devices
      • Surgical Sealants
Deal Status
  • Final
Deal Type
  • Acquisition
    • Divestiture/Spin-Out

Related Companies

UsernamePublicRestriction

Register